Serveur d'exploration sur la rapamycine et les champignons - Curation (Accueil)

Index « MedMesh.i » - entrée « In Vitro Techniques »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
In Situ Nick-End Labeling < In Vitro Techniques < Incidence  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000725 (2017) A. Frey [Allemagne] ; E-M Ecker [Allemagne] ; K. Piras-Straub [Allemagne] ; A. Walker [Allemagne] ; T G Hofmann [Allemagne] ; J. Timm [Allemagne] ; B B Singer [Allemagne] ; G. Gerken [Allemagne] ; K. Herzer [Allemagne]Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
000E65 (2014) Mingzhe Weng ; Wei Gong ; Mingzhe Ma ; Bingfeng Chu ; Yiyu Qin ; Mingdi Zhang ; Xueqing Lun ; Grant Mcfadden ; Peter Forsyth ; Yong Yang [République populaire de Chine] ; Zhiwei QuanTargeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.
000F25 (2013) Christoph Aderhold [Allemagne] ; Anne Faber ; Guido Manuel Grobschmidt ; Anja Chakraborty ; Andre Bockmayer ; Claudia Umbreit ; Richard Birk ; Jens Stern-Straeter ; Karl Hörmann ; Johannes David SchultzSmall molecule-based chemotherapeutic approach in p16-positive and -negative HNSCC in vitro.
001492 (2009) David W. Good [États-Unis] ; Thampi George ; Bruns A. WattsLipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes.
001530 (2009) Tatsuhiro Sato [États-Unis] ; Akio Nakashima ; Lea Guo ; Fuyuhiko TamanoiSpecific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein.
001757 (2006) Kimberly F. Raab-Graham [États-Unis] ; Patrick C G. Haddick ; Yuh Nung Jan ; Lily Yeh JanActivity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites.
001803 (2005) Shantha Kumar [États-Unis] ; Marianne J. Skeen ; Yaffa Adiri ; Hyseuk Yoon ; Vaiva D. Vezys ; Aron E. Lukacher ; Brian D. Evavold ; H Kirk Ziegler ; Jeremy M. BossA cytokine promoter/yellow fluorescent protein reporter transgene serves as an early activation marker of lymphocyte subsets.
001838 (2005) Amal O. Amer [États-Unis] ; Michele S. SwansonAutophagy is an immediate macrophage response to Legionella pneumophila.
001A52 (1999) B L Musgrave [Canada] ; T. Phu ; J J Butler ; A P Makrigiannis ; D W HoskinMurine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
001B58 (1979) K. Singh ; S. Sun ; C. VézinaRapamycin (AY-22,989), a new antifungal antibiotic. IV. Mechanism of action.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "In Vitro Techniques" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "In Vitro Techniques" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    In Vitro Techniques
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020